Crispr-Cas9 News
Scientist He Jiankui said in November that he used a gene-editing technology known as CRISPR-Cas9 to alter the embryonic genes of twin girls born that month.
Researchers found that removing the mutated protein by disrupting the mutant myociln results in lowered intraocular pressure, which in turn prevents glaucomatous damage to the eye.
While rare overall, it is one of the most common inherited diseases of the retina.
Loading...